AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 168 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $124,988 | -64.8% | 16,086 | -56.2% | 0.00% | – |
| Q2 2023 | $355,556 | +61414.9% | 36,731 | -30.4% | 0.00% | – |
| Q1 2023 | $578 | +1.0% | 52,776 | -60.2% | 0.00% | – |
| Q4 2022 | $572 | -99.6% | 132,600 | +563.0% | 0.00% | – |
| Q3 2022 | $150,000 | -25.4% | 20,000 | 0.0% | 0.00% | – |
| Q2 2022 | $201,000 | -97.8% | 20,000 | -97.3% | 0.00% | -100.0% |
| Q1 2022 | $9,194,000 | +151.3% | 742,595 | +364.1% | 0.01% | +150.0% |
| Q4 2021 | $3,659,000 | -62.7% | 160,000 | -63.9% | 0.00% | -60.0% |
| Q3 2021 | $9,812,000 | +362.0% | 443,390 | +171.2% | 0.01% | +150.0% |
| Q1 2021 | $2,124,000 | +1017.9% | 163,508 | +1092.9% | 0.00% | – |
| Q4 2020 | $190,000 | -98.1% | 13,707 | -97.9% | 0.00% | -100.0% |
| Q3 2020 | $9,844,000 | +321.0% | 668,278 | +364.4% | 0.01% | +300.0% |
| Q2 2020 | $2,338,000 | -60.5% | 143,891 | -64.7% | 0.00% | -76.9% |
| Q1 2020 | $5,921,000 | -85.0% | 408,096 | -79.0% | 0.01% | -73.5% |
| Q4 2019 | $39,408,000 | +923.1% | 1,945,094 | +169.6% | 0.05% | +716.7% |
| Q3 2019 | $3,852,000 | +173.0% | 721,459 | +236.5% | 0.01% | +100.0% |
| Q2 2019 | $1,411,000 | -8.2% | 214,406 | -9.3% | 0.00% | 0.0% |
| Q1 2019 | $1,537,000 | +1297.3% | 236,424 | +872.8% | 0.00% | – |
| Q4 2017 | $110,000 | -55.8% | 24,303 | -38.8% | 0.00% | – |
| Q3 2017 | $249,000 | +22.7% | 39,700 | +19.9% | 0.00% | – |
| Q2 2017 | $203,000 | -71.1% | 33,099 | -65.4% | 0.00% | -100.0% |
| Q1 2017 | $703,000 | +375.0% | 95,758 | +35.5% | 0.00% | – |
| Q4 2016 | $148,000 | +6.5% | 70,693 | +41.4% | 0.00% | – |
| Q2 2016 | $139,000 | -67.1% | 50,000 | -65.6% | 0.00% | -100.0% |
| Q1 2016 | $423,000 | +17.8% | 145,200 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $359,000 | -12.9% | 145,200 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $412,000 | -6.2% | 145,200 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $439,000 | -30.1% | 145,200 | +0.8% | 0.00% | 0.0% |
| Q1 2015 | $628,000 | – | 144,061 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
| ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
| DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
| NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
| Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
| HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
| SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |